Two biotechnology companies end U.S. IPO lull
February 02, 2016 at 21:25 PM EST
Feb 2 (Reuters) - Biotechnology companies BeiGene Ltd and Editas Medicine Inc priced the first initial public offerings of 2016 in the United States on Tuesday, following a bout of stock market volatility that shut the IPO market for over a month.
